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iInfrapopliteal Percutaneous Transluminal Angioplasty Versus Bypass
Surgery as First-Line Strategies in Critical Leg Ischemia: A Propensity
Score Analysis
SoderstromMI, Arvela EM, KorhonenM et al. Ann Surg 2010;252:765-73.
Conclusion: Infrapopliteal percutaneous angioplasty, when feasible,
can be an effective first-line strategy achieving similar long-term results as
bypass surgery in patients with critical limb ischemia (CLI) when redo
procedures are actively used.
Summary: Retrospective studies of patient characteristics in endovas-
cular and surgical trials often differ significantly. Propensity score analysis can
be used to adjust for important differences between treatment groups. In
this study, propensity score analysis was used to compare outcomes in
patients who underwent percutaneous transluminal angioplasty (PTA) or
bypass surgery of infrapopliteal arteries. The study cohort consisted of 1023
nonrandomized patients treated for CLI, with 262 endovascular and 761
surgical revascularization procedures performed on tibial or pedal arteries. A
propensity score was used for stratification and for adjustment in multivari-
able analysis. Choice of treatment was based on physician preference and
treatment feasibility. PTA and bypass surgery achieved similar 5-year limb
salvage (75.3% vs 76.0%), similar survival (47.5% vs 43.3%), and amputation-
free survival (37.7% vs 32.7%). Rates of freedom from further revasculariza-
tion were also similar (73.3% vs 74.4%). Freedom from surgical revascular-
ization was higher after bypass surgery (94.3% vs 86.2%, P  .001).
Outcomes were similar with propensity-score matched pairs except for
freedom from surgical revascularization, which was higher in the bypass
surgery group (91.4% vs 85.3% at 5 years, P  .045). In patients who
underwent isolated infrapopliteal revascularization, PTA was associated with
better limb salvage (75.5% vs 68.0%, P .042). Differences in freedom from
surgical revascularization were not significant (78.8% vs 85.2%, P  .17).
The difference in the limb salvage rate was not maintained in propensity
score-matched pairs (P  .12).
Comment: Propensity score analysis is an interesting mathematical
exercise. However, as pointed out by Dr J. F. Hamming in a discussion after
the article, the authors are still comparing “apples with oranges,” in that
endovascular treatment was reserved for patients with shorter lesions and
mostly stenosis and not occlusions. The underlying problem of trying to
compare treatment modalities in patients with differing extent of disease still
exists. What the paper really demonstrates is that it is possible to be
reasonably good at individualizing treatment in patients with CLI. The
overall effectiveness of the different treatment modalities in patients with
equal burden of disease is not answered by this study.
Evaluation for Clinical Predictors of Positive Temporal Artery Biopsy
in Giant Cell Arteritis
Rieck KL, Kermni TA, Thomsen KM. J Oral Maxillofac Surg 2011;69:
36-40.
Conclusions: A positive temporal artery biopsy specimen is more likely
if patients present with weight loss or pain with mastication. Corticosteroid
therapy before temporal artery biopsy does not affect positivity of a temporal
artery biopsy specimen.
Summary: In patients aged 50 years, temporal arteritis (TA) is the
most common systemic vasculitis. Tenderness of the scalp or new onset of
headache are common complaints. Ocular manifestations of TA include
decreased vision, diplopia, and amaurosis fugax, and up to 20% of patients
may develop irreversible visual loss from optic nerve ischemia. Pain with
mastication is present in 50% of patients (Salbarani C, et al; Lancet 2008;
372:234). However, many patients present with predominately constitu-
tional symptoms such as weight loss, fatigue, or fever. Inflammatory mark-
ers, such as erythrocyte sedimentation rate and C-reactive protein, are
frequently elevated in patients with TA, but they are not specific. Diagnosis
of TA can therefore be difficult. An abnormal finding on a temporal artery
biopsy specimen is a part of the American College of Rheumatology criteria
for diagnosis of TA (Hunder GG, et al; Arthritis Rheum 1990;33:112);
however, up to two-thirds of temporal artery biopsy specimens are negative.
It would therefore be useful to determine if there are clinical parameters that
most likely correlate with TA to identify patients who will most likely benefit
from treatment while waiting to undergo a temporal artery biopsy (Youngee
BR; Mayo Clin Proc 2004;79:483). In this study, the authors examined
clinical parameters associated with a positive temporal artery biopsy speci-
men in patients with symptoms suggestive of TA. This was a retrospective
study of 82 consecutive patients who underwent temporal artery biopsies by
a single surgeon at a single institution. Medical records were reviewed for
clinical symptoms, laboratory findings, final diagnosis, and biopsy results.
t
the microscopic examination suggested evidence of arteritis in 22 patients
26.8%). In two patients, TA was clinically diagnosed with a negative
emporal artery biopsy specimen. Patients presenting with weight loss or
ain with mastication were most likely to have a positive temporal artery
iopsy specimen (odds ratio, 4.5 [95% CI, 1.45-13.93] and odds ratio, 3.71
95% CI, 1.28-10.76]). Laboratory findings did not predict a positive
emporal artery biopsy specimen. Use of steroids before the temporal artery
iopsy was not associated with a decreased likelihood of a positive specimen.
Comment: High doses of corticosteroids are the initial treatment of
A. These drugs are clearly not benign in the elderly patient. For logistical
nd referral reasons, a temporal artery biopsy specimen may not be available
s rapidly as desirable. If one does not wish to treat all patients suspected of
A before biopsy results, the study provides some guidance for determining
atients who are at the highest risk of actually having a positive biopsy
pecimen. Pain with mastication and weight loss appear to be more impor-
ant parameters in predicting a positive temporal artery biopsy specimen than
aboratory markers of inflammation. It is also useful to know that prednisone
herapy will not decrease the likelihood of a positive temporal artery biopsy
pecimen, at least if the biopsy occurs relatively soon after the beginning of
teroid therapy.
arotid Ultrasound Identifies High Risk Subclinical Atherosclerosis in
dults with Low Framingham Risk Scores
leid MF, Lester SJ, Wiedenbeck TL, et al. J Am Soc Echocardiography
010;23:802-8.
Conclusion: A high percentage of young to middle-aged individuals
ith a Framingham Risk Score (FRS) indicating 5% risk of cardiovascular
vents have abnormal carotid ultrasound findings associated with an in-
reased risk for cardiovascular events.
Summary: Atherosclerosis-related clinical events are presumably pre-
eded by a period of asymptomatic atherosclerosis. The FRS is a population-
ased algorithm recommended to identify at-risk individuals and determine
he aggressiveness of preventive therapy (JAMA 2001;285:2486-97). How-
ver, population-based risk algorithms do not quantify atherosclerosis. They
rovide only a probability of cardiovascular events over a relatively short
xed period, usually 10 years. The FRS risk assessment also does not
ncorporate family history, premature coronary artery disease, remote smok-
ng history, impaired fasting glucose, triglyceride levels, or waist circumfer-
nce. Tests for subclinical atherosclerosis are therefore sometimes recom-
ended to add incremental information and provide more accurate risk
tratification. The authors tested the hypothesis that patients with a low
5%) FRS 10-year risk for a first cardiovascular event and intermediate (6%
o 20%) FRS 10-year risk will have increased cardiovascular risk as deter-
ined by an abnormal carotid intima-media thickness (IMT). This study
ncluded individuals aged 65 years who were not taking statins and who
id not have diabetes or a history of coronary artery disease, but who did
ndergo a determination of carotid IMT and plaque for primary interven-
ion. Clinical variables analyzed included lipid values, family history of
oronary artery disease, FRS, and subsequent pharmacotherapy recommen-
ations.
The study comprised 441 individuals who were a mean age of 49.7 
.9 years. Of these patients, 184 (42%, 95% CI, 37.3%-46.5%) had high-risk
arotid IMT findings (carotid IMT 75th percentile adjusted for age, sex,
ace, or presence of plaque). In 336 individuals with the lowest FRS score of
5%, 127 (38%, 95% CI, 32.6%-43.0%) had high-risk carotid ultrasound
ndings. The treating physicians recommended lipid-lowering therapy for
7 individuals (61%) with a FRS 5% and high-risk carotid ultrasound
ndings.
Comment: This study indicates a disconnect between the risk
ssessment by the FRS and carotid IMT. Studies have also found high-
isk carotid ultrasound findings influence physicians to prescribe aspirin
r lipid-lowering therapies (Wyman RA, et al; Am Heart J 2007;154:
072-7 and Korcarz CE, et al; J Am Soc Echocardiogr 2008;21:1156-
2). However, although physicians may make treatment decisions based
n a finding of increased carotid IMT, it appears that observing changes
n IMT to monitor effects of drug therapy will not reduce subsequent
linical events. A practical point may be that carotid IMT can be used to
dentify patients at increased risk for cardiovascular events, but once
reatment is initiated, subsequent studies to monitor effectiveness of
reatment may not be needed.
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